微创医学

目的探讨输尿管留置双J管后相关临床症状及处理措施。方法选择住院行微创手术并输尿管留置双J管患者196例，随机分成观察组和对照组，每组98例。观察组术后口服托特罗定2 mg/次，1次/d进行干预，连续6周至拔除双J管；对照组未服托特罗定干预。总结分析其出现的相关临床症状及处理措施。结果观察组膀胱过度活动症、尿痛、腰部疼痛发生率均低于对照组，两组比较，差异有统计学意义（P＜0.05）；两组尿路感染、发热、肉眼血尿发生率比较，差异无统计学意义（P＞0.05）。结论口服托特罗定能明显降低输尿管术后留置双J管患者OAB症状、尿痛及腰腹部疼痛症状的发生率，但对尿路感染、发热和肉眼血尿症状的改善作用不明显。

ObjectiveTo investigate the clinical symptoms and treatment of retaining double J tuble in ureter. MethodsA total of 196 patients were retained double J tube in ureter, and then were randomly divided into two groups, observation group and control group, 98 cases in each group. The patients in observation group were administrated oral Tolterodine 2mg per day consecutively for six weeks until the removal of double J tube. The patients in control group did not take Tolterodine intervention. The related clinical symptoms and treatment measures were summarized and analyzed. ResultsThe occurrence of bladder overactive, dysuria, pain in the waist of observation group were lower than those of the control group, the differences were statistically significant (P＜0.05) . There was no significant difference in the incidence of urinary tract infection, fever and gross hematuria between the two groups (P＞0.05). ConclusionsTolterodine could significantly reduced the incidences of OAB symptom, dysuria and waist abdomen ache,But the improvement of the symptoms of urinary tract infection, fever and gross hematuria is not obvious.

无